Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?

Wimmer K, Hlauschek D, Balic M, Pfeiler G, Singer CF, Halper S, Steger G, Suppan C, Gampenrieder SP, Helfgott R, Egle D, Filipits M, Jakesz R, Sölkner L, Fesl C, Gnant M, Fitzal F, Greil R.

Breast Cancer Res Treat. 2024 Jan 25. doi: 10.1007/s10549-023-07186-6. Online ahead of print. PMID: 38273214.

https://pubmed.ncbi.nlm.nih.gov/38273214/